Ming Yu

Dr. Ming Yu


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2021 in Oncology Reports
Verified
Journal Article
Open access
PDF file
HJHongchao Jiang
Hongchao Jiang
JTJiaolian Tang
Jiaolian Tang
LQLijuan Qiu
Lijuan Qiu
ZZZhen Zhang
Zhen Zhang
SSShulan Shi
Shulan Shi
QSQiangming Sun
Qiangming Sun
Semaphorin 4D (Sema4D) is highly expressed in a variety of tumors and is associated with high invasion, poor prognosis and poor therapeutic response. However, the expression and role of Sema4D in leukemia remains unclear. The present study investigated the expression of Sema4D in pediatric leukemia and its effects in leukemia cells. The results demonstrated that Sema4D protein was highly expressed in peripheral blood mononuclear cells of patients with pediatric leukemia, and high levels of soluble Sema4D were also observed in the plasma of these patients. Sema4D knockdown induced cell cycle arrest in G0/G1 phase, inhibited proliferation and promoted apoptosis in BALL‑1 cells, while Sema4D overexpression exhibited the opposite effect. In Jurkat cells, Sema4D knockdown inhibited proliferation and promoted apoptosis, while Sema4D overexpression decreased the abundance of the cells in the G0/G1 phase of the cell cycle and promoted proliferation. Sema4D overexpression also increased the migratory capacity of Jurkat cells and the invasive capacity of BALL‑1 cells. The phosphorylation level of PI3K was decreased in both Sema4D knocked‑down Jurkat and BALL‑1 cells, and the phosphorylation level of ERK was decreased in Sema4D knocked‑down BALL‑1 cells. The phosphorylation levels of PI3K, ERK and AKT were elevated in patients with pediatric leukemia, and were correlated to the increased Sema4D expression. Sema4D overexpression was associated with a shorter overall survival in patients with acute myeloid leukemia. Overall, the results of the present study indicated that Sema4D serves an important role in leukemia development by activating PI3K/AKT and ERK signaling, and it may be used as a potential target for the diagnosis and treatment of leukemia.

1 June 2010 in Developmental Biology
Verified
Journal Article
Closed access
MRMichael D. Risley
Michael D. Risley
CCChristopher Clowes
Christopher Clowes
MYMing Yu
Ming Yu
KMKaren Mitchell
Karen Mitchell
KHKathryn Hentges
Kathryn Hentges

1 March 2002 in Journal of General Virology
Verified
Journal Article
Closed access
MYMing Yu
Ming Yu
EWEnxiu Wang
Enxiu Wang
YLYoufang Liu
Youfang Liu
DCDianjun Cao
Dianjun Cao
NJNingyi Jin
Ningyi Jin
GGGeorge F. Gao
George F. Gao
Paramyxoviruses may adopt a similar fusion mechanism to other enveloped viruses, in which an anti-parallel six-helix bundle structure is formed post-fusion in the heptad repeat (HR) regions of the envelope fusion protein. In order to understand the fusion mechanism and identify fusion inhibitors of Newcastle disease virus (NDV), a member of the Paramyxoviridae family, we have developed an E. coli system that separately expresses the F protein HR1 and HR2 regions as GST fusion proteins. The purified cleaved HR1 and HR2 have subsequently been assembled into a stable six-helix bundle heterotrimer complex. Furthermore, both the GST fusion protein and the cleaved HR2 show virus–cell fusion inhibition activity (IC50 of 1·07–2·93 μM). The solubility of the GST–HR2 fusion protein is much higher than that of the corresponding peptide. Hence this provides a plausible method for large-scale production of HR peptides as virus fusion inhibitors.

10 August 2016 in Genesis
Verified
Journal Article
Open access
PDF file
MYMing Yu
Ming Yu
SASalma Al‐Dallal
Salma Al‐Dallal
LALatifa Al‐Haj
Latifa Al‐Haj
SPShiraj Panjwani
Shiraj Panjwani
AMAkina S. McCartney
Akina S. McCartney
KHKathryn Hentges
Kathryn Hentges
The mouse zinc‐finger gene Zfp521 (also known as ecotropic viral insertion site 3; Evi3; and ZNF521 in humans) has been identified as a B‐cell proto‐oncogene, causing leukemia in mice following retroviral insertions in its promoter region that drive Zfp521 over‐expression. Furthermore, ZNF521 is expressed in human hematopoietic cells, and translocations between ZNF521 and PAX5 are associated with pediatric acute lymphoblastic leukemia. However, the regulatory factors that control Zfp521 expression directly have not been characterized. Here we demonstrate that the transcription factors SPI1 (PU.1) and HOXC13 synergistically regulate Zfp521 expression, and identify the regions of the Zfp521 promoter required for this transcriptional activity. We also show that SPI1 and HOXC13 activate Zfp521 in a dose‐dependent manner. Our data support a role for this regulatory mechanism in vivo, as transgenic mice over‐expressing Hoxc13 in the fetal liver show a strong correlation between Hoxc13 expression levels and Zfp521 expression. Overall these experiments provide insights into the regulation of Zfp521 expression in a nononcogenic context. The identification of transcription factors capable of activating Zfp521 provides a foundation for further investigation of the regulatory mechanisms involved in ZFP521‐driven cell differentiation processes and diseases linked to Zfp521 mis‐expression.

10 October 2025 in Leukemia Research
Verified
Journal Article
Closed access
JLJuan Li
Juan Li
SSShulan Shi
Shulan Shi
KZKefu Zhu
Kefu Zhu
LZLinyang Zhe
Linyang Zhe
TLTianle Lu
Tianle Lu
HJHongchao HONG Jiang
Hongchao HONG Jiang

4 April 2008 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
MYMing Yu
Ming Yu
FLFeng-Ting Liu
Feng-Ting Liu
ANAdrian C. Newland
Adrian C. Newland
LJLi Jia
Li Jia